Philip M. Hanno, MD, MPH
Philip M. Hanno, a Urology Times editorial consultant, is professor of urology at the University of Pennsylvania, Philadelphia.
http://www.urologytimes.com
Cyclosporine: Hope, caution for severe interstitial cystitis
The results of recent studies are promising, but use of cyclosporine for patients with severe interstitial cystitis is not to be taken lightly.
Repeal of sustainable growth rate, Independent Payment Advisory Board top American Urological Association health policy priorities
AUA Health Policy Chair Steven M. Schlossberg, MD, MBA, discusses important health policy issues in urology and how the AUA is addressing them.
Group visits for urology deliver efficiency, patient satisfaction
Simultaneously giving patients added contact with their physician while also allowing them to talk about their condition with others, group shared appointments are applicable to a number of urologic conditions.
Role of prostate cancer prevention will be clarified with ongoing data analysis
Leonard G. Gomella, MD, co-investigator of the REDUCE trial, discusses what has been learned from three prostate cancer prevention trials and the future of prostate cancer chemoprevention.
Nurse practitioners, physician assistants will help alleviate urology work force shortage, according to AUA
Thomas J. Rohner, Jr, MD, chairman of the AUA's Urology Work Force Task Force, explains the scope of the work force shortage and the goals of the non-physician provider initiative.
Prostate biopsy associated with significant risks, according to new studies
Authors from two recent studies discuss the risks men face in undergoing biopsy as well as the steps urologists are taking to minimize these risks.
Pelvic pain research focuses on role of central nervous system, phenotypes
Magnus Fall, MD, PhD, discusses the EAU guidelines and new research directions in chronic pelvic pain.
Stress urinary incontinence treatment evolves with growth of synthetics
In this interview, Gopal H. Badlani, MD, discusses the shift to mid-urethral sling placement, the growth of synthetic graft materials, and the reasons for these changes in the management of female stress urinary incontinence.
Research points to expanding role of botulinum toxin
In this podcast, Dr. Phil Hanno interviews Dr. Michael Chancellor on the potential role of botulinum toxin in urology.
'IC' by any other name? Consensus is needed soon
The lack of standardization and agreement [about what to call interstitial cystitis] are major impediments to the progress we all hope to see.

Poll

View Results